We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease

By LabMedica International staff writers
Posted on 25 Apr 2025
Print article
Image: Single-cell analysis of neutrophils can identify increased population of activated neutrophils in newly diagnosed vasculitis patients (Photo courtesy of University of Osaka)
Image: Single-cell analysis of neutrophils can identify increased population of activated neutrophils in newly diagnosed vasculitis patients (Photo courtesy of University of Osaka)

Neutrophils, once believed to be uniform in nature, have been discovered to exhibit significant diversity. These immune cells, which play a crucial role in fighting infections, are also implicated in autoimmune diseases. Now, new research has revealed that a specific subset of neutrophils can predict disease relapse early, potentially paving the way for more tailored treatment approaches.

A study published in Nature Communications and led by a multi-institutional research team from The University of Osaka (Osaka, Japan) explored the dominant cell types in the blood of patients at the early stages of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This disease, caused by inflammation in the blood vessels, can lead to organ dysfunction. The research team enrolled six patients and seven healthy controls for comparison, collecting around 180,000 white blood cells. These cells were subjected to single-cell analysis to examine their genetic characteristics and surface proteins. The analysis of the transcriptome and proteome revealed a significantly higher proportion of two specific neutrophil subpopulations in the patients compared to healthy individuals. Notably, the researchers found an increase in a highly activatable subset of neutrophils in the patients. These cells were found to be responsive to interferon-gamma (IFN-g), a key protein involved in inflammation.

Among the patients, those showing the highest expression of IFN-g response genes were found to have persistent vasculitis symptoms even after treatment, suggesting that this particular neutrophil subpopulation plays a role in the persistent nature of vasculitis. To further investigate, the team analyzed the levels of IFN-g in stored serum samples from 37 patients, some of whom were newly diagnosed and others who had undergone treatment. The results were striking. Of the 24 new-onset patients assessed, the six with the highest serum IFN-g concentrations all experienced relapses, suggesting that measuring IFN-g levels could serve as an early indicator of disease relapse. This research offers a deeper understanding of the immune mechanisms underlying ANCA-associated vasculitis and suggests potential new strategies for disease monitoring and treatment. By identifying specific neutrophil populations involved in disease progression, these findings could lead to more personalized therapies, ultimately improving outcomes for patients suffering from this rare but serious condition.

Related Links:
University of Osaka 

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.